All lobbying filings

EVONIK CORPORATION

Lobbying for EVONIK CORPORATION · Manufacturer of specialty chemicals

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 3

S 623
No IRIS Act of 2025
HR 1415
No IRIS Act of 2025
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …

Lobbying activity 7

Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

Chemicals/Chemical Industry

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

Environment/Superfund

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Budget/Appropriations

FY26 appropriations actions H.R. 5371/ P.L. 119-37 FY2026 Continuing Appropriations, Agriculture, Leg. Branch & Extensions Act

Taxation/Internal Revenue Code

General issues related to corporate tax

Trade (domestic/foreign)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.